All Type of News
Seniority-based culture losing momentum in pharmaceutical industry
The seniority-based culture has long have been a catalyst for the growth of pharmaceutical firms and at the same time as a headache.
Although having the oldest as a leader in a group embraces boosting effects and i...
Pediatric cancer treatment costs increased by 152% in 5 years
The Health Insurance Review and Assessment Service said Monday that the national health insurance spent 73 billion won treating pediatric cancers last year, a 152.1 percent rise from 29 billion won in 2006.
In 2010...
Crystal Genomics not to acquire BexPharm Korea
Crystal Genomics and BexPharm Korea has recently agreed not to proceed any merger and acquisition (M&A) between both companies.
Crystal Genomics announced the M&A plan with BexPharm last May with a strong interest ...
Boryung Group to build 150 billion won plant
Boryung Pharmaceutical Group said Monday it will invest 150 billion won to build a complex plant producing drugs and other pharmaceutical products by 2014.
“To streamline the production of our healthcare products, ...
Government urged to boost medical service
The government will have to ease rules to encourage foreign hospitals to enter free economic zones and bring in advanced medical technologies, while re-emphasizing a wider role of supermarkets and convenient stores to...
KPTA seeking to expand customer bases in US and China
The Korea Pharmaceutical Manufacturers Association (KPMA) has unveiled its plan to help Korean companies enlarge and diversify their customer bases in the United States and China.
In a meeting with representatives ...
KFDA to approve Boehringer Ingelheim’s novel, oral anticoagulant
The Korea Food and Drug Administration is likely to approve Pradaxa (dabigatran etexilate), Boehringer Ingelheim’s novel, oral direct thrombin inhibitor for stroke risk reduction in patients with non-valvular atrial f...
Pharmaceutical companies eye non-pharmaceutical markets
Over-the-counter (OTC) drugs may emerge as the blue chips for domestic pharmaceutical companies as they are trying to find a breakthrough amid sagging momentum in the prescription market, which is forecast to become c...
Pharmaceutical companies fare well with generic drugs
Korea’s leading drugmakers saw their flagship generic products’ sales increasing due to robust demand last year, while the revenues in homegrown drugs were still discouraging.
According to Ubist market data, Hanmi ...
Multinational firms eyes local partnership
More and more foreign-invested firms are trying to seek strategic alliances with local firms for co-marketing of new drugs to effectively minimize outlays for sales and marketing.
Such alliance is widespread as ev...
